JP2016538574A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016538574A5 JP2016538574A5 JP2016554543A JP2016554543A JP2016538574A5 JP 2016538574 A5 JP2016538574 A5 JP 2016538574A5 JP 2016554543 A JP2016554543 A JP 2016554543A JP 2016554543 A JP2016554543 A JP 2016554543A JP 2016538574 A5 JP2016538574 A5 JP 2016538574A5
- Authority
- JP
- Japan
- Prior art keywords
- dulcitol
- minutes
- dianhydrogalactitol
- hplc
- formic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- BDAGIHXWWSANSR-UHFFFAOYSA-N formic acid Chemical compound OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 72
- FBPFZTCFMRRESA-GUCUJZIJSA-N Galactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-GUCUJZIJSA-N 0.000 claims description 38
- AAFJXZWCNVJTMK-GUCUJZIJSA-N (1S,2R)-1-[(2S)-oxiran-2-yl]-2-[(2R)-oxiran-2-yl]ethane-1,2-diol Chemical compound C([C@@H]1[C@H](O)[C@H](O)[C@H]2OC2)O1 AAFJXZWCNVJTMK-GUCUJZIJSA-N 0.000 claims description 36
- 229950000758 Dianhydrogalactitol Drugs 0.000 claims description 33
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 31
- 239000012535 impurity Substances 0.000 claims description 29
- 235000019253 formic acid Nutrition 0.000 claims description 24
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 24
- 238000010828 elution Methods 0.000 claims description 19
- 238000000105 evaporative light scattering detection Methods 0.000 claims description 15
- 238000004458 analytical method Methods 0.000 claims description 14
- 238000004128 high performance liquid chromatography Methods 0.000 claims description 14
- 238000009472 formulation Methods 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 12
- 239000007857 degradation product Substances 0.000 claims description 8
- 239000000539 dimer Substances 0.000 claims description 8
- 150000001875 compounds Chemical class 0.000 claims description 6
- 230000014759 maintenance of location Effects 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 6
- 238000004587 chromatography analysis Methods 0.000 claims description 5
- 239000002879 Lewis base Substances 0.000 claims description 3
- 239000000356 contaminant Substances 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- 239000007789 gas Substances 0.000 claims description 3
- 238000002347 injection Methods 0.000 claims description 3
- 239000007924 injection Substances 0.000 claims description 3
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 claims description 3
- 239000006199 nebulizer Substances 0.000 claims description 3
- 229910052757 nitrogen Inorganic materials 0.000 claims description 3
- 239000000047 product Substances 0.000 claims description 3
- 230000035945 sensitivity Effects 0.000 claims description 3
- 239000000741 silica gel Substances 0.000 claims description 3
- 229910002027 silica gel Inorganic materials 0.000 claims description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicium dioxide Chemical group O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 32
- 238000000034 method Methods 0.000 description 4
- 230000004048 modification Effects 0.000 description 3
- 238000006011 modification reaction Methods 0.000 description 3
- 239000003480 eluent Substances 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- 238000004811 liquid chromatography Methods 0.000 description 2
- 230000004075 alteration Effects 0.000 description 1
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/083,135 | 2013-11-18 | ||
US14/083,135 US9029164B2 (en) | 2012-02-27 | 2013-11-18 | Analytical methods for analyzing and determining impurities in dianhydrogalactitol |
PCT/US2014/066087 WO2015074025A1 (en) | 2013-11-18 | 2014-11-18 | Hplc analysis of impurities in dianhydrogalactitol |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2016538574A JP2016538574A (ja) | 2016-12-08 |
JP2016538574A5 true JP2016538574A5 (ko) | 2017-12-28 |
Family
ID=53058168
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016554543A Pending JP2016538574A (ja) | 2013-11-18 | 2014-11-18 | ジアンヒドロガラクチトール中の不純物のhplc分析 |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP3071555A4 (ko) |
JP (1) | JP2016538574A (ko) |
KR (1) | KR20160108315A (ko) |
CN (1) | CN107529337B (ko) |
AU (1) | AU2014348232A1 (ko) |
CA (1) | CA2931088A1 (ko) |
CL (1) | CL2016001197A1 (ko) |
IL (1) | IL245713A0 (ko) |
MX (1) | MX2016006457A (ko) |
WO (1) | WO2015074025A1 (ko) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106397360A (zh) * | 2015-07-29 | 2017-02-15 | 广西梧州制药(集团)股份有限公司 | 叔丁醇在去水卫矛醇或其组合物冷冻干燥过程中的应用 |
US10591445B2 (en) | 2015-11-25 | 2020-03-17 | Del Mar Pharmaceuticals (Bc) Ltd. | Methods for analysis and resolution of preparations of dianhydrogalactitol and derivatives or analogs thereof |
CN105445407B (zh) * | 2015-12-29 | 2017-04-19 | 成都普思生物科技股份有限公司 | 一种山桐子中脂肪酸和维生素e的检测方法 |
US10927363B2 (en) | 2016-04-04 | 2021-02-23 | Mie University | DNA sequence and expression vector for alginate lyase |
KR102270026B1 (ko) * | 2020-01-31 | 2021-06-28 | 현대약품 주식회사 | (3s)-3-(4-(3-(1,4-다이옥사스파이로[4,5]데스-7-엔-8-일)벤질옥시)페닐)헥스-4-이노익산의 품질 평가 방법 |
CN114113352A (zh) * | 2020-08-28 | 2022-03-01 | 深圳波顿香料有限公司 | 发酵液中内酯型槐糖酯含量的测定方法 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04297868A (ja) * | 1991-03-27 | 1992-10-21 | Tonen Corp | オリゴ糖の分析方法 |
JPH09229920A (ja) * | 1996-02-26 | 1997-09-05 | Kao Corp | グラジェント液体クロマトグラフィー溶離液の処理方法 |
US6060525A (en) * | 1996-03-01 | 2000-05-09 | Dionix Corporation | Removal of borate in chromatography |
WO2000042225A1 (en) * | 1999-01-14 | 2000-07-20 | Board Of Supervisors Of Louisiana State Universityand Agricultural And Mechanical College | Process for the separation of sugars |
US20060148732A1 (en) * | 2000-11-17 | 2006-07-06 | Gutterman Jordan U | Inhibition of NF-kappaB by triterpene compositions |
JP2004294384A (ja) * | 2003-03-28 | 2004-10-21 | National Agriculture & Bio-Oriented Research Organization | 1−デオキシノジリマイシンの測定方法 |
CA2819769C (en) * | 2003-07-18 | 2016-06-28 | Oakwood Laboratories, L.L.C. | Prevention of molecular weight reduction of the polymer, impurity formation and gelling in polymer compositions |
NZ551448A (en) * | 2004-05-20 | 2011-02-25 | Novartis Vaccines & Diagnostic | Analysis of liquid chromotography eluates |
JP2008076340A (ja) * | 2006-09-25 | 2008-04-03 | Toppan Printing Co Ltd | 高感度検出方法およびその検出装置 |
KR101578792B1 (ko) * | 2007-10-25 | 2015-12-21 | 엑셀리시스, 인코포레이티드 | 트로판 화합물 |
WO2011092120A1 (en) * | 2010-01-29 | 2011-08-04 | Nerviano Medical Sciences S.R.L. | 6,7- dihydroimidazo [1,5-a] pyrazin-8 (5h) - one derivatives as protein kinase modulators |
KR20140037005A (ko) * | 2010-08-18 | 2014-03-26 | 델 마 파마슈티컬스 인코포레이티드 | 디안하이드로갈락티톨과 같은 치환된 헥시톨을 제조하는 방법 |
CN102008541B (zh) * | 2010-10-08 | 2012-07-04 | 广西中医学院 | 无糖型复方扶芳藤制剂中3种主要活性成分的同时检测方法 |
MX2014010312A (es) * | 2012-02-27 | 2015-04-14 | Del Mar Pharmaceuticals | Metodos analiticos mejorados para analizar y determinar impurezas en dianhidrogalactitol. |
BE1020835A5 (nl) * | 2012-03-20 | 2014-06-03 | Maes Francis N V | Werkwijze voor het vervaardigen van een plantenextract, i.h.b. uit desmodium. |
-
2014
- 2014-11-18 EP EP14862051.1A patent/EP3071555A4/en not_active Withdrawn
- 2014-11-18 CA CA2931088A patent/CA2931088A1/en not_active Abandoned
- 2014-11-18 KR KR1020167016274A patent/KR20160108315A/ko not_active Application Discontinuation
- 2014-11-18 AU AU2014348232A patent/AU2014348232A1/en not_active Abandoned
- 2014-11-18 JP JP2016554543A patent/JP2016538574A/ja active Pending
- 2014-11-18 CN CN201480073454.XA patent/CN107529337B/zh active Active
- 2014-11-18 MX MX2016006457A patent/MX2016006457A/es unknown
- 2014-11-18 WO PCT/US2014/066087 patent/WO2015074025A1/en active Application Filing
-
2016
- 2016-05-18 IL IL245713A patent/IL245713A0/en unknown
- 2016-05-18 CL CL2016001197A patent/CL2016001197A1/es unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2016538574A5 (ko) | ||
Štěpánová et al. | Determination of impurities and counterions of pharmaceuticals by capillary electromigration methods | |
Zhao et al. | Salting-out homogeneous liquid–liquid extraction approach applied in sample pre-processing for the quantitative determination of entecavir in human plasma by LC–MS | |
Singh et al. | Development and validation of a HPLC method for the determination of trans-resveratrol in spiked human plasma | |
CN108780075A (zh) | 伊马替尼基因杂质的高灵敏度分析方法 | |
CN103163226A (zh) | 30种氨基酸同时定量检测方法及试剂盒制备 | |
Paek et al. | Hydrophilic interaction liquid chromatography–tandem mass spectrometry for the determination of levosulpiride in human plasma | |
Thiele et al. | Direct analysis of underivatized amino acids in plant extracts by LC-MS-MS | |
Inoue et al. | An approach to on-line electrospray mass spectrometric detection of polypeptide antibiotics of enramycin for high-speed counter-current chromatographic separation | |
CN104359998B (zh) | 一种气相色谱-串联质谱检测甲磺酸甲酯的方法 | |
CN108508127A (zh) | 一种测定空气中醛酮化合物的高效液相色谱法 | |
Wahlen et al. | Comparison of different liquid chromatography conditions for the separation and analysis of organotin compounds in mussel and oyster tissue by liquid chromatography–inductively coupled plasma mass spectrometry | |
Jandera et al. | Effect of water on the retention on diol and amide columns in hydrophilic interaction liquid chromatography | |
Zhao et al. | Simultaneous determination nucleosides in marine organisms using ultrasound‐assisted extraction followed by hydrophilic interaction liquid chromatography–electrospray ionization time‐of‐flight mass spectrometry | |
Sano et al. | Analysis of triorganotin compounds in water samples by hydrophilic interaction liquid chromatography–electrospray ionization-mass spectrometry | |
JP2016538574A (ja) | ジアンヒドロガラクチトール中の不純物のhplc分析 | |
CN110849980A (zh) | 一种l-丙氨酸异丙酯中对映异构体含量的检测方法 | |
Thiele et al. | Direct analysis of underivatized amino acids in plant extracts by LC-MS/MS (improved method) | |
Baranowska et al. | Enantioselective determination of metoprolol and its metabolites in human urine high-performance liquid chromatography with fluorescence detection (HPLC–FLD) and tandem mass spectrometry (MS/MS) | |
Cizmarova et al. | A simple and green capillary electrophoresis-mass spectrometry method for therapeutic drug monitoring of colistin in clinical plasma samples | |
Zhang et al. | A highly sensitive method for analyzing marker phytoplankton pigments: Ultra‐high‐performance liquid chromatography‐tandem triple quadrupole mass spectrometry | |
HS et al. | Application of liquid chromatography coupled with mass spectrometry in the impurity profiling of drug substances and products | |
de Bruijn et al. | Validated bioanalytical method for the quantification of RGB-286638, a novel multi-targeted protein kinase inhibitor, in human plasma and urine by liquid chromatography/tandem triple-quadrupole mass spectrometry | |
Sun et al. | High performance liquid chromatography–electrospray ionization mass spectrometric determination of isosorbide 5-mononitrate in human plasma | |
Tagami et al. | Simultaneous identification of 18 illegal adulterants in dietary supplements by using high-performance liquid chromatography-mass spectrometry |